FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1946390825> ?p ?o ?g. }

• W1946390825 abstract "Medication-overuse headache (MOH) is a chronic disorder that results from the overuse of analgesics drugs, triptans or other acute headache compounds. Although the exact mechanisms underlying MOH remain still unknown, several studies suggest that it may be associated with development of central sensitization, which may cause cutaneous allodynia (CA). Furthermore, the epidemiology of drug-induced disorders suggests that medication overuse could lead to nephrotoxicity. The aim of this work was to confirm and validate the results obtained from previous proteomics studies, in which we analyzed the urinary proteome of MOH patients in comparison with healthy non-abusers individuals.MOH patients were divided into groups on the basis of the drug abused: triptans, non-steroidal anti-inflammatory drugs (NSAIDs) and mixtures, (mainly containing indomethacin, paracetamol and, in some cases, caffeine). Healthy subjects, with a history of normal renal function, were used as controls. In this study, four proteins that were found differentially expressed in urine, and, on the basis of the literature review, resulted related to kidney diseases, were verified by Western Blot and Enzyme-linked Immunosorbent Assay (ELISA); Prostaglandin-H2 D-synthase (PTGDS), uromodulin (UROM), alpha-1-microglobulin (AMBP) and cystatin-C (CYSC).Western blot analysis allowed to validate our previous proteomics data, confirming that all MOH patients groups show a significant over-excretion of urinary PTGDS, UROM, AMBP and CYSC (excluding triptans group for this latter), in comparison with controls. Moreover, the expression of PTGDS was further evaluated by ELISA. Also by this assay, a significant increase of PTGDS was observed in all MOH abusers, according to 2-DE and Western blot results.In this study, we confirmed previous findings concerning urinary proteins alterations in MOH patients, identified and demonstrated the over-expression of PTGDS, UROM, AMBP, and CYSC, particularly in NSAIDs and mixtures abusers. Over-expression of these proteins have been related to renal dysfunction and probably, PTGDS, to the development of CA. The detection and confirmation of this proteins pattern represent a promising tool for a better understanding of potential nephrotoxicity induced by drugs overuse and may enhance awareness related to the MOH-associated risks, even in absence of clinical symptoms." @default.
• W1946390825 created "2016-06-24" @default.
• W1946390825 creator A5019399975 @default.
• W1946390825 creator A5053716434 @default.
• W1946390825 creator A5062899092 @default.
• W1946390825 creator A5069328169 @default.
• W1946390825 creator A5071179624 @default.
• W1946390825 creator A5073776156 @default.
• W1946390825 creator A5074758288 @default.
• W1946390825 creator A5079779151 @default.
• W1946390825 date "2015-08-15" @default.
• W1946390825 modified "2023-09-27" @default.
• W1946390825 title "Validation of potential candidate biomarkers of drug-induced nephrotoxicity and allodynia in medication-overuse headache" @default.
• W1946390825 cites W1511203783 @default.
• W1946390825 cites W1973370945 @default.
• W1946390825 cites W1981137514 @default.
• W1946390825 cites W1996586644 @default.
• W1946390825 cites W1999183933 @default.
• W1946390825 cites W2013499403 @default.
• W1946390825 cites W2016045274 @default.
• W1946390825 cites W2029892742 @default.
• W1946390825 cites W2039549107 @default.
• W1946390825 cites W2040792219 @default.
• W1946390825 cites W2046393754 @default.
• W1946390825 cites W2050568800 @default.
• W1946390825 cites W2054277979 @default.
• W1946390825 cites W2054563583 @default.
• W1946390825 cites W2054986497 @default.
• W1946390825 cites W2063083371 @default.
• W1946390825 cites W2072800583 @default.
• W1946390825 cites W2080451800 @default.
• W1946390825 cites W2081225918 @default.
• W1946390825 cites W2081861656 @default.
• W1946390825 cites W2087502121 @default.
• W1946390825 cites W2096198144 @default.
• W1946390825 cites W2098377860 @default.
• W1946390825 cites W2100891309 @default.
• W1946390825 cites W2103649969 @default.
• W1946390825 cites W2105813236 @default.
• W1946390825 cites W2110106197 @default.
• W1946390825 cites W2115886467 @default.
• W1946390825 cites W2115940379 @default.
• W1946390825 cites W2116603171 @default.
• W1946390825 cites W2120528742 @default.
• W1946390825 cites W2128635872 @default.
• W1946390825 cites W2128692107 @default.
• W1946390825 cites W2133338739 @default.
• W1946390825 cites W2133949006 @default.
• W1946390825 cites W2136610456 @default.
• W1946390825 cites W2139991445 @default.
• W1946390825 cites W2140353743 @default.
• W1946390825 cites W2146306684 @default.
• W1946390825 cites W2150027687 @default.
• W1946390825 cites W2152534506 @default.
• W1946390825 cites W2153958515 @default.
• W1946390825 cites W2168193025 @default.
• W1946390825 cites W2168357775 @default.
• W1946390825 cites W2171876802 @default.
• W1946390825 cites W2316377639 @default.
• W1946390825 cites W256167749 @default.
• W1946390825 cites W2993996962 @default.
• W1946390825 cites W4293247451 @default.
• W1946390825 doi "https://doi.org/10.1186/s10194-015-0559-8" @default.
• W1946390825 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4536253" @default.
• W1946390825 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26272683" @default.
• W1946390825 hasPublicationYear "2015" @default.
• W1946390825 type Work @default.
• W1946390825 sameAs 1946390825 @default.
• W1946390825 citedByCount "13" @default.
• W1946390825 countsByYear W19463908252016 @default.
• W1946390825 countsByYear W19463908252017 @default.
• W1946390825 countsByYear W19463908252018 @default.
• W1946390825 countsByYear W19463908252019 @default.
• W1946390825 countsByYear W19463908252020 @default.
• W1946390825 countsByYear W19463908252021 @default.
• W1946390825 countsByYear W19463908252022 @default.
• W1946390825 crossrefType "journal-article" @default.
• W1946390825 hasAuthorship W1946390825A5019399975 @default.
• W1946390825 hasAuthorship W1946390825A5053716434 @default.
• W1946390825 hasAuthorship W1946390825A5062899092 @default.
• W1946390825 hasAuthorship W1946390825A5069328169 @default.
• W1946390825 hasAuthorship W1946390825A5071179624 @default.
• W1946390825 hasAuthorship W1946390825A5073776156 @default.
• W1946390825 hasAuthorship W1946390825A5074758288 @default.
• W1946390825 hasAuthorship W1946390825A5079779151 @default.
• W1946390825 hasBestOaLocation W19463908251 @default.
• W1946390825 hasConcept C126189478 @default.
• W1946390825 hasConcept C126322002 @default.
• W1946390825 hasConcept C2777119127 @default.
• W1946390825 hasConcept C2778541695 @default.
• W1946390825 hasConcept C2780035454 @default.
• W1946390825 hasConcept C2780091579 @default.
• W1946390825 hasConcept C71924100 @default.
• W1946390825 hasConcept C98274493 @default.
• W1946390825 hasConceptScore W1946390825C126189478 @default.
• W1946390825 hasConceptScore W1946390825C126322002 @default.
• W1946390825 hasConceptScore W1946390825C2777119127 @default.
• W1946390825 hasConceptScore W1946390825C2778541695 @default.
• W1946390825 hasConceptScore W1946390825C2780035454 @default.
• W1946390825 hasConceptScore W1946390825C2780091579 @default.

• next